Case ReportMetastatic Alveolar Soft Part Sarcoma of the Spinal Cord: A Case Report and Review of Literature
Introduction
Alveolar soft part sarcoma (ASPS) is a rare, malignant soft-tissue neoplasm that constitutes approximately 0.5%–1.0% of all soft-tissue sarcomas.1, 2 This tumor is uniquely characterized by a nonreciprocal chromosomal translocation, t(X;17)(p11.2;q25), that results in the formation of a novel fusion gene, ASPL-TFE3.3 In addition to its highly specific genetic makeup, ASPS also exhibits distinctive histologic features, which include an alveolar pattern of clustered polygonal cells separated by fibrovascular septae and the presence of diastase-resistant periodic acid-Schiff–positive crystalline cytoplasmic granules.4, 5 The most common presentation of ASPS is in the skeletal muscle and deep soft tissue of the leg or thigh; however, a majority of patients, estimated at 65% in one study, present with disseminated stage IV disease.6 Similar to other sarcomas, ASPS has a predisposition for metastasizing to lung and bone while also possessing an unusual propensity to metastasize to the brain.2, 7 Consequently, small series of patients with brain metastases have been described in the literature.6, 8, 9, 10 Interestingly, cases of patients with suspected primary intracranial manifestations of ASPS also have been reported.5, 9, 11, 12, 13, 14 Primary tumors and metastases also have been noted in close proximity to the spinal cord within the bony spinal column.15, 16, 17 However, to our knowledge, there are no reports of ASPS involvement of the spinal cord in the English literature. Here, we present a unique and unfortunate case of a 23-year-old woman with disseminated disease to the lung and brain who subsequently developed an intramedullary thoracic spinal cord metastatic focus of ASPS.
Section snippets
Clinical History
A 23-year-old woman presented with headaches and an enlarging painless mass in her distal right thigh that was detected approximately 1 year before consultation. Subsequent magnetic resonance imaging (MRI) of the head revealed multiple brain metastases, with the largest measuring 1.7 × 1.37 cm in the right occipital lobe (Figure 1A–C). These images did not demonstrate meningeal enhancement. An MRI of the right thigh confirmed the presence of a 17.9 × 6.3 × 7.6-cm mass, whereas computed
Discussion
ASPS is most prevalent in younger individuals, with a peak incidence between 15 and 35 years and a female predominance during the first 2 decades of life.6, 7, 18 On presentation, the primary tumor most commonly develops in the deep soft tissues of the lower extremities and trunk in adults, while generally originating in the head and neck region in children.7, 12, 16 In many cases, patients detect a soft, asymptomatic mass, which prompts them to seek medical care. Although localized ASPS often
Conclusions
We present a case of disseminated ASPS with a unique metastatic presentation, whereby a metastasis was observed in the intramedullary spinal cord with no surrounding bony lesions. This case may represent the first instance when ASPS has involved the spinal cord in any manner. Treatment with complete resection may have halted the progression of neurologic motor and sensory symptoms, even though long-term neurological improvement could not be assessed. Knowledge of this case could be useful when
Acknowledgements
All authors were responsible for the preparation, review, or approval of the manuscript, and all are included in the decision to submit the manuscript for publication.
References (26)
- et al.
Sunitinib in advanced alveolar soft part sarcoma: Evidence of a direct antitumor effect
Ann Oncol
(2011) - et al.
Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?
Neoplasia
(2008) - et al.
Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases
Int J Radiat Oncol Biol Phys
(2010) - et al.
Treatment of metastatic, refractory alveolar soft part sarcoma
J Pediatr Hematol Oncol
(2016) - et al.
Brain metastasis in bone and soft tissue cancersa review of incidence, interventions, and outcomes
Sarcoma
(2014) - et al.
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
Oncogene
(2001) - et al.
Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis
Ultrastruct Pathol
(2016) - et al.
Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1-TFE3 fusion: case Report
Neuropathology
(2009) - et al.
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution
Cancer
(2001) - et al.
Alveolar soft-part sarcoma
JAMA
(1966)
Sarcoma metastatic to the brain: a series of 35 cases and considerations from 27 years of experience
J Neurooncol
Sarcoma metastatic to the brain
Cancer
Sarcoma metastatic to the brain: results of surgical treatment
Neurosurgery
Cited by (2)
Molecular Landscape in Alveolar Soft Part Sarcoma: Implications for Molecular Targeted Therapy
2018, Biomedicine and PharmacotherapyCitation Excerpt :The number of ASPS recorded articles in PubMed has grown gradually over last 20 years (since 1997 to 2017) (Fig. 1). Unlike most sarcomas, ASPS has high tendency for metastasis [20]. This type of cancer has tendency toward distant metastasis and invasion especially to brain and lungs [21]; However uncommon sites of metastasis such as distal phalanx of hand has been reported [22].
Comparative Combinatorial Implications and Theranostics of Immunotherapy in the Impediment of Alveolar Soft Part Sarcoma
2022, Current Pharmaceutical Design
Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.